Product specifications CAS Registry Number 170851-70-4 Reported purity 98.5% Form Lyophilized laboratory research material Intended use Qualified in vitro laboratory research only
Anyone taking other medications, since a prescriber should check for interactions before adding a compounded injection
(Reuters) Known risk factors for NAION include: Diabetes High blood pressure High cholesterol Sleep apnea Smoking Medications that affect blood flow or circulation Because GLP-1 drugs influence metabolic function, blood sugar levels, and physiological processes that may affect circulation, plaintiffs in GLP-1 lawsuits allege that drug manufacturers knew or should have known about the potential risk of optic nerve damage and failed to adequately warn patients and healthcare providers
G., Hardan, A., Vagnucci, A., Pollock, B., Luther, J., Buttenfield, J., Verfaille, S., & Kupfer, D